Resolvyx Presents Data Demonstrating Potential For Resolvin Therapeutics To Treat Corneal And Retinal Eye Diseases At ARVO 2010 Meeting

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010…

More: continued here

Filed under: Eye Health on May 9th, 2010